The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes

Hiromitsu Hara, Atsunobu Takeda, Michiyo Takeuchi, Andrew C. Wakeham, Annick Itié, Masafumi Sasaki, Tak W. Mak, Akihiko Yoshimura, Kikuo Nomoto, Hiroki Yoshida

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Negative selection is a process to delete potentially autoreactive clones in developing thymocytes. Programmed cell death or apoptosis is thought to play an important role in this selection process. In this study, we investigated the role of apoptotic protease-activating factor 1 (Apaf1), a mammalian homologue of CED-4, in programmed cell death during the negative selection in thymus. There was no developmental abnormality in thymocytes from newborn Apaf1-/- mice in terms of CD4 and CD8 expression pattern and thymocyte number. Clonal deletion by endogenous male H-Y Ag of Apaf1-deficient thymocytes with transgenic expression of H-Y Ag-specific TCRs (H-Y Tg/Apaf1-/- thymocytes) was normally observed in lethally irradiated wild-type mice reconstituted with fetal liver-derived hemopoietic stem cells. Clonal deletion induced in vitro by a bacterial superantigen was also normal in fetal thymic organ culture. Thus, Apaf1-mediated pathway of apoptosis is dispensable for the negative selection of thymocytes. However, H-Y Tg/Apaf1-/- thymocytes showed partial resistance to H-Y peptide-induced deletion in vitro as compared with H-Y Tg/Apaf1+/- thymocytes, implicating the Apaf1-mediated apoptotic pathway in the negative selection in a certain situation. In addition, the peptide-induced deletion was still observed in H-Y Tg/Apaf1-/- thymocytes in the presence of a broad spectrum caspase inhibitor, z-VAD-fmk, suggesting the presence of caspase-independent cell death pathway playing roles during the negative selection. We assume that mechanisms for the negative selection are composed of several cell death pathways to avoid failure of elimination of autoreactive clones.

Original languageEnglish
Pages (from-to)2288-2295
Number of pages8
JournalJournal of Immunology
Volume168
Issue number5
Publication statusPublished - 2002 Mar 1
Externally publishedYes

Fingerprint

Apoptotic Protease-Activating Factor 1
Thymocytes
Apoptosis
Cell Death
Clonal Deletion
Clone Cells
Superantigens
Peptides
Caspase Inhibitors
Organ Culture Techniques
Caspases
Thymus Gland
Stem Cells

ASJC Scopus subject areas

  • Immunology

Cite this

Hara, H., Takeda, A., Takeuchi, M., Wakeham, A. C., Itié, A., Sasaki, M., ... Yoshida, H. (2002). The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. Journal of Immunology, 168(5), 2288-2295.

The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. / Hara, Hiromitsu; Takeda, Atsunobu; Takeuchi, Michiyo; Wakeham, Andrew C.; Itié, Annick; Sasaki, Masafumi; Mak, Tak W.; Yoshimura, Akihiko; Nomoto, Kikuo; Yoshida, Hiroki.

In: Journal of Immunology, Vol. 168, No. 5, 01.03.2002, p. 2288-2295.

Research output: Contribution to journalArticle

Hara, H, Takeda, A, Takeuchi, M, Wakeham, AC, Itié, A, Sasaki, M, Mak, TW, Yoshimura, A, Nomoto, K & Yoshida, H 2002, 'The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes', Journal of Immunology, vol. 168, no. 5, pp. 2288-2295.
Hara H, Takeda A, Takeuchi M, Wakeham AC, Itié A, Sasaki M et al. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. Journal of Immunology. 2002 Mar 1;168(5):2288-2295.
Hara, Hiromitsu ; Takeda, Atsunobu ; Takeuchi, Michiyo ; Wakeham, Andrew C. ; Itié, Annick ; Sasaki, Masafumi ; Mak, Tak W. ; Yoshimura, Akihiko ; Nomoto, Kikuo ; Yoshida, Hiroki. / The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. In: Journal of Immunology. 2002 ; Vol. 168, No. 5. pp. 2288-2295.
@article{b971a9194c2a43c0b35e8c1701d4a56d,
title = "The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes",
abstract = "Negative selection is a process to delete potentially autoreactive clones in developing thymocytes. Programmed cell death or apoptosis is thought to play an important role in this selection process. In this study, we investigated the role of apoptotic protease-activating factor 1 (Apaf1), a mammalian homologue of CED-4, in programmed cell death during the negative selection in thymus. There was no developmental abnormality in thymocytes from newborn Apaf1-/- mice in terms of CD4 and CD8 expression pattern and thymocyte number. Clonal deletion by endogenous male H-Y Ag of Apaf1-deficient thymocytes with transgenic expression of H-Y Ag-specific TCRs (H-Y Tg/Apaf1-/- thymocytes) was normally observed in lethally irradiated wild-type mice reconstituted with fetal liver-derived hemopoietic stem cells. Clonal deletion induced in vitro by a bacterial superantigen was also normal in fetal thymic organ culture. Thus, Apaf1-mediated pathway of apoptosis is dispensable for the negative selection of thymocytes. However, H-Y Tg/Apaf1-/- thymocytes showed partial resistance to H-Y peptide-induced deletion in vitro as compared with H-Y Tg/Apaf1+/- thymocytes, implicating the Apaf1-mediated apoptotic pathway in the negative selection in a certain situation. In addition, the peptide-induced deletion was still observed in H-Y Tg/Apaf1-/- thymocytes in the presence of a broad spectrum caspase inhibitor, z-VAD-fmk, suggesting the presence of caspase-independent cell death pathway playing roles during the negative selection. We assume that mechanisms for the negative selection are composed of several cell death pathways to avoid failure of elimination of autoreactive clones.",
author = "Hiromitsu Hara and Atsunobu Takeda and Michiyo Takeuchi and Wakeham, {Andrew C.} and Annick Iti{\'e} and Masafumi Sasaki and Mak, {Tak W.} and Akihiko Yoshimura and Kikuo Nomoto and Hiroki Yoshida",
year = "2002",
month = "3",
day = "1",
language = "English",
volume = "168",
pages = "2288--2295",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes

AU - Hara, Hiromitsu

AU - Takeda, Atsunobu

AU - Takeuchi, Michiyo

AU - Wakeham, Andrew C.

AU - Itié, Annick

AU - Sasaki, Masafumi

AU - Mak, Tak W.

AU - Yoshimura, Akihiko

AU - Nomoto, Kikuo

AU - Yoshida, Hiroki

PY - 2002/3/1

Y1 - 2002/3/1

N2 - Negative selection is a process to delete potentially autoreactive clones in developing thymocytes. Programmed cell death or apoptosis is thought to play an important role in this selection process. In this study, we investigated the role of apoptotic protease-activating factor 1 (Apaf1), a mammalian homologue of CED-4, in programmed cell death during the negative selection in thymus. There was no developmental abnormality in thymocytes from newborn Apaf1-/- mice in terms of CD4 and CD8 expression pattern and thymocyte number. Clonal deletion by endogenous male H-Y Ag of Apaf1-deficient thymocytes with transgenic expression of H-Y Ag-specific TCRs (H-Y Tg/Apaf1-/- thymocytes) was normally observed in lethally irradiated wild-type mice reconstituted with fetal liver-derived hemopoietic stem cells. Clonal deletion induced in vitro by a bacterial superantigen was also normal in fetal thymic organ culture. Thus, Apaf1-mediated pathway of apoptosis is dispensable for the negative selection of thymocytes. However, H-Y Tg/Apaf1-/- thymocytes showed partial resistance to H-Y peptide-induced deletion in vitro as compared with H-Y Tg/Apaf1+/- thymocytes, implicating the Apaf1-mediated apoptotic pathway in the negative selection in a certain situation. In addition, the peptide-induced deletion was still observed in H-Y Tg/Apaf1-/- thymocytes in the presence of a broad spectrum caspase inhibitor, z-VAD-fmk, suggesting the presence of caspase-independent cell death pathway playing roles during the negative selection. We assume that mechanisms for the negative selection are composed of several cell death pathways to avoid failure of elimination of autoreactive clones.

AB - Negative selection is a process to delete potentially autoreactive clones in developing thymocytes. Programmed cell death or apoptosis is thought to play an important role in this selection process. In this study, we investigated the role of apoptotic protease-activating factor 1 (Apaf1), a mammalian homologue of CED-4, in programmed cell death during the negative selection in thymus. There was no developmental abnormality in thymocytes from newborn Apaf1-/- mice in terms of CD4 and CD8 expression pattern and thymocyte number. Clonal deletion by endogenous male H-Y Ag of Apaf1-deficient thymocytes with transgenic expression of H-Y Ag-specific TCRs (H-Y Tg/Apaf1-/- thymocytes) was normally observed in lethally irradiated wild-type mice reconstituted with fetal liver-derived hemopoietic stem cells. Clonal deletion induced in vitro by a bacterial superantigen was also normal in fetal thymic organ culture. Thus, Apaf1-mediated pathway of apoptosis is dispensable for the negative selection of thymocytes. However, H-Y Tg/Apaf1-/- thymocytes showed partial resistance to H-Y peptide-induced deletion in vitro as compared with H-Y Tg/Apaf1+/- thymocytes, implicating the Apaf1-mediated apoptotic pathway in the negative selection in a certain situation. In addition, the peptide-induced deletion was still observed in H-Y Tg/Apaf1-/- thymocytes in the presence of a broad spectrum caspase inhibitor, z-VAD-fmk, suggesting the presence of caspase-independent cell death pathway playing roles during the negative selection. We assume that mechanisms for the negative selection are composed of several cell death pathways to avoid failure of elimination of autoreactive clones.

UR - http://www.scopus.com/inward/record.url?scp=0036499206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036499206&partnerID=8YFLogxK

M3 - Article

VL - 168

SP - 2288

EP - 2295

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -